Filing Details
- Accession Number:
- 0001209191-16-101142
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-22 19:38:54
- Reporting Period:
- 2016-02-17
- Filing Date:
- 2016-02-22
- Accepted Time:
- 2016-02-22 19:38:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1396814 | Pacira Pharmaceuticals Inc. | PCRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1309702 | J Paul Hastings | C/O Pacira Pharmaceuticals, Inc. 5 Sylvan Way, Suite 300 Parsippany NJ 07054 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-02-17 | 2,000 | $13.98 | 4,853 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2016-02-17 | 1,000 | $10.81 | 5,853 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-02-17 | 3,000 | $60.00 | 2,853 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-02-17 | 2,000 | $0.00 | 2,000 | $13.98 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-02-17 | 1,000 | $0.00 | 1,000 | $10.81 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,000 | 2021-06-02 | No | 4 | M | Direct | |
| 0 | 2022-06-04 | No | 4 | M | Direct |
Footnotes
- The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- The stock options vested and became exercisable in 24 equal monthly installments beginning on July 2, 2011.
- The stock options vested and became exercisable in twelve equal monthly installments beginning on July 5, 2012.
Billionaire Hedge Funds
